NASDAQ:LYEL | Operating Income | Lyell Immunopharma, Inc.

Complete source-backed operating income history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$47.34M
2026-03-31-$44.26M
2025-12-31-$127.64M
2025-09-30-$37.25M
2025-06-30-$47.14M
2025-03-31-$57.37M
2024-12-31-$201.15M
2024-09-30-$50.51M
2024-06-30-$51.53M
2024-03-31-$55.58M
2023-12-31-$59.51M
2023-09-30-$59.04M
2023-06-30-$65.91M
2023-03-31-$62.56M
2022-12-31-$14.78M
2022-09-30-$66.44M
2022-06-30-$37.26M
2022-03-31-$68.58M
2021-12-31-$47.54M
2021-09-30-$49.16M
2021-06-30-$62.71M
2021-03-31-$55.37M
2020-12-31-$39.52M
2020-09-30-$36.84M
2020-06-30-$102.57M

Annual Operating Income

DateOperating Income
2025-12-31-$269.4M
2024-12-31-$358.76M
2023-12-31-$247.01M
2022-12-31-$187.06M
2021-12-31-$214.78M
2020-12-31-$211.94M
2019-12-31-$102.09M